Search
for
Sort by
Research 691–720 of 1000+
- Meta-analysis identifies novel risk loci and yields systematic insights into the biology of male-pattern baldness
- Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Generation of comparative pharmacophoric model for steroidal 5α-reductase I and II inhibitors: A 3D-QSAR study on 6-azasteroids
- Urinary Incontinence due to Overactive Detrusor Muscle: A Rare Side Effect of Venlafaxine
- Author response: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- Medical Therapies for Treatment of BPH: Special Considerations in Elderly Men
- Misdiagnosis of eosinophilic cystitis: A case report and literature review
- Androgenetic alopecia - just a cosmetic defect or a biomarker and risk factor for systemic diseases? - literature review
- Musculoskeletal and body composition response to high-dose testosterone with finasteride after chronic incomplete spinal cord injury—a randomized, double-blind, and placebo-controlled pilot study
- Anti-inflammatory Effects in LPS-treated RAW 264.7 Cells and the Influences on Drug Metabolizing Enzyme Activities by the Traditional Herbal Formulas, Yongdamsagan-Tang and Paljung-san
- Androgens’ Effects across the Lifespan in Men and Animal Models
- Decision letter: Effects of lifelong testosterone exposure on health and disease using Mendelian randomization
- The post-finasteride syndrome: possible etiological mechanisms and symptoms
- Treatment options for polycystic ovary syndrome
- Finasteride
- Folliculin, the Product of the Birt-Hogg-Dube Tumor Suppressor Gene, Interacts with the Adherens Junction Protein p0071 to Regulate Cell-Cell Adhesion
- 5α-Reductases In Human Physiology: an Unfolding Story
- Finasteride and sexual side effects
- Aging in the sebaceous gland
- The Double Edge Sword of Testosterone’s Role in the COVID-19 Pandemic
- Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study
- Cutaneous Lesions in the Rat Following Administration of an Irreversible Inhibitor of erbB Receptors, Including the Epidermal Growth Factor Receptor
- Fixed-dose combination PRO 160/120 of sabal and urtica extracts improves nocturia in men with LUTS suggestive of BPH: re-evaluation of four controlled clinical studies
- May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications?
- Finasteride Use and Risk of Male Breast Cancer: A Case–Control Study Using Individual-Level Registry Data from Denmark, Finland, and Sweden
- Testicular Steroidogenesis
- Simultaneous spectrophotometric determination of finasteride and tadalafil in recently FDA approved Entadfi™ capsules
- Oral Presentations: Abstracts of the Urological Society of Australia and New Zealand Annual Scientific Meeting, 25–28 February 2023, Melbourne, Australia
- Sexual, physical, and overall adverse effects in patients treated with 5α-reductase inhibitors: a systematic review and meta-analysis
- Finasteride versus dutasteride: a real-world economic evaluation.